Efficacy and safety of the direct switch to indacaterol/glycopyrronium from salmeterol/fluticasone in non‐frequently exacerbating COPD patients: The FLASH randomized controlled trial - Concepedia

Concepedia

Publication | Open Access

Efficacy and safety of the direct switch to indacaterol/glycopyrronium from salmeterol/fluticasone in non‐frequently exacerbating COPD patients: The FLASH randomized controlled trial

DOI Full Paper Access

25

Citations

15

References

2018

Year

Peter Frith, Samiha Ashmawi, Srikanth V. Krishnamurthy, Alev Gürgün, Sashka Hristoskova, Virginia Pilipovic, A. Hamann, Arthur Backer, Petter Olsson, Κonstantinos Κostikas,

Abstract

FLASH demonstrated that a direct switch to IND/GLY from SFC improved pre-dose FEV<sub>1</sub> and FVC in COPD patients with up to one exacerbation in the previous year. No new safety signals were identified.

References

	Year	Citations

Page 1